Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sugentech, a Major Digital Ovulation Test Manufacturer Begins Distribution in the US

Sugentech
Posted on: 13 Sep 18
Sugentech, a Major Digital Ovulation Test Manufacturer Begins Distribution in the US Sugentech, a Korea based manufacturer of digital and ovulation tests partners with CGETC, Inc., a fulfillment and marketing company located in City of Industry to launch their product line in the US.

PR Newswire

CITY OF INDUSTRY, Calif., Sept. 13, 2018

CITY OF INDUSTRY, Calif., Sept. 13, 2018 /PRNewswire-PRWeb/ -- Sugentech, the maker of Surearly Digital Ovulation and Pregnancy Tests, has announced a promotion on its product line until the end of this month which are available through Amazon.com

Surearly Digital Ovulation Test was released in 2017 in the US through their strategic US partner, CGETC, Inc., who handles all of their fulfillment and shipping needs. Sugentech is a strong player in the digital pregnancy and ovulation test market which includes Clearblue, First Response, and E.P.T. Surearly Digital Ovulation Test was registered as a medical device since 2014 through the US FDA.

About Surearly Digital Ovulation Test:
Surearly Ovulation Test determines the LH (Luteinizing Hormone) surge in its urine test and gives a simple answer of YES or NO. With the use of ovulation tests, couples trying to conceive can increase the chances. The Surearly Digital Ovulation Test is over 99% accurate and has been tested to detect the LH Surge. Hard interpretation of when and if you are at the surge point is no longer necessary. If the test results yields a simple answer of YES or NO, which takes out the guess of any blurry lines.

As referenced in an article by Coherent Marketing Insights (printed Jan. 29, 2018), Sugentech is a major player in the digital pregnancy&ovulation testing market. Majority of the market share is contributed by companies such as Swiss Precision Diagnostics GmbH, Church & Dwight Co, Inc., Gregory Pharmaceutical Holdings, Inc., and Sugentech, Inc.

About Sugentech:
Sugentech is a FDA registered, ISO13485 certified In-Vitro Diagnostic Company with various and robust Bio-IT convergence technologies, started as a Research Institute Spin-off Company of Ministry of Science and ICT in Korea.

Along with the Surearly Digital Ovulation Test, Sugentech is also specialized in developing professional IVD(in-vitro diagnostic) products such as Full-Automated Immunoblot System and Quantitative POCT(Point-Of-Care Testing) Immunoassay Analyzer(Inclix ™) detecting various biomarkers.

Sugentech's CEO, Dr. Mijin Sohn, a powerful and strong willed woman, whose vision in healthcare business has been quoted "All of our employees, including myself, will continue to present a new future in the field of in-vitro diagnostics, with a constant passion and responsibility to achieve the mission of helping people live healthier lives." is female powerhouse CEO to keep watch on in the US as a potential key player in the self-diagnostics including the digital pregnancy and ovulation.

Surearly Ovulation Tests are available now on Amazon.com.

 

SOURCE Sugentech

PR Newswire
www.prnewswire.com

Last updated on: 13/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.